Pottegård A - Search Results

1

Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort.

Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, Christiansen CF, Sørensen HT, Johansen NB, Brun NC, Voldstedlund M, Støvring H, Thomsen MK, Christensen S, Gubbels S, Krause TG, Mølbak K, Thomsen RW. Reilev M, et al. Among authors: pottegard a. Int J Epidemiol. 2020 Oct 1;49(5):1468-1481. doi: 10.1093/ije/dyaa140. Int J Epidemiol. 2020. PMID: 32887982 Free PMC article.

2

[Children prefer bottled amoxicillin].

Pottegård A, Hallas J. Pottegård A, et al. Ugeskr Laeger. 2010 Dec 13;172(50):3468-70. Ugeskr Laeger. 2010. PMID: 21156107 Danish.

3

Physicians' and pharmacies' overview of patients' medication. An analysis of fidelity coefficients.

Pottegård A, Hallas J. Pottegård A, et al. Eur J Clin Pharmacol. 2011 Sep;67(9):919-24. doi: 10.1007/s00228-011-1026-3. Epub 2011 Mar 12. Eur J Clin Pharmacol. 2011. PMID: 21399945 Free article.

4

Pharmaceutical interventions on prescription problems in a Danish pharmacy setting.

Pottegård A, Hallas J, Søndergaard J. Pottegård A, et al. Int J Clin Pharm. 2011 Dec;33(6):1019-27. doi: 10.1007/s11096-011-9580-4. Epub 2011 Nov 15. Int J Clin Pharm. 2011. PMID: 22083723

5

Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes.

Meegaard PM, Holck LH, Pottegård A, Madsen H, Hallas J. Meegaard PM, et al. Among authors: pottegard a. Dan Med J. 2012 Feb;59(2):A4383. Dan Med J. 2012. PMID: 22293053 Free article.

6

The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.

Pottegård A, Bjerregaard BK, Glintborg D, Hallas J, Moreno SI. Pottegård A, et al. Eur J Clin Pharmacol. 2012 Oct;68(10):1443-50. doi: 10.1007/s00228-012-1265-y. Epub 2012 Mar 21. Eur J Clin Pharmacol. 2012. PMID: 22434389

7

The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

Pottegård A, Bjerregaard BK, Glintborg D, Kortegaard LS, Hallas J, Moreno SI. Pottegård A, et al. Eur J Clin Pharmacol. 2013 Mar;69(3):589-98. doi: 10.1007/s00228-012-1344-0. Epub 2012 Jul 19. Eur J Clin Pharmacol. 2013. PMID: 22811260

8

Concurrent use of tramadol and oral vitamin K antagonists and the risk of excessive anticoagulation: a register-based nested case-control study.

Pottegård A, Meegaard PM, Holck LH, Christensen Rd, Madsen H, Hallas J. Pottegård A, et al. Eur J Clin Pharmacol. 2013 Mar;69(3):641-6. doi: 10.1007/s00228-012-1363-x. Epub 2012 Jul 31. Eur J Clin Pharmacol. 2013. PMID: 22847619

9

Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study.

Pottegård A, Friis S, Andersen M, Hallas J. Pottegård A, et al. Br J Clin Pharmacol. 2013 May;75(5):1356-64. doi: 10.1111/bcp.12001. Br J Clin Pharmacol. 2013. PMID: 23043261 Free PMC article.

10

Cancer risk in long-term users of vitamin K antagonists: a population-based case-control study.

Pottegård A, Friis S, Hallas J. Pottegård A, et al. Int J Cancer. 2013 Jun 1;132(11):2606-12. doi: 10.1002/ijc.27905. Epub 2012 Nov 2. Int J Cancer. 2013. PMID: 23065946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters